News

1 2 3 4 5
NEWS

SOTIO receives orphan-drug designation for Ovarian Active Cellular Immunotherapy

SOTIO has received orphan-drug designation from the U.S. Food and Drug Administration (FDA) for the active cellular immunotherapy (ACI) DCVAC/OvCa.

This website uses cookies; by continuing to use this page, you consent to their use. About cookies